← Leaderboards
Yiping Zhu
University Of Rochester
$1,448,307
Attributed
$1,448,307
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $601.3K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,448,307 · 3
By mechanism
R21$847,000 · 2
R01$601,307 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Brendan F Boyce$11,520,354
- Eric M. Phizicky$13,586,027
- Zhenqiang Yao$2,493,956
- Dmitri Ermolenko$6,671,319
- Elizabeth Joan Grayhack$2,509,213
Others in their field
Other Rising Stars on “Knock-Out”
- Saad J. Kenderian · Mayo Clinic Rochester$4,027,286
- Kenneth Schultz · Trethera Corporation$3,694,806
- Xu Chen · University Of California, San Francisco$3,581,285
- Russell Jones · Van Andel Research Institute$3,253,755
- Jessica Boyle · University Of Iowa$2,844,441
- Yue Wang · Florida State University$2,782,476
Research focus
Knock-OutVirusViral PathogenesisIntegration Host FactorsVirus DiseasesViralCellsMolecularPlayGenetic TranscriptionCofactorBindingTranscriptional ActivationEpigenetic ProcessTranscriptional RegulationComplexChromatinRegulationProductionStructurePreventT-LymphocyteClustered Regularly Interspaced Short Palindromic Repeats2019-Ncov
Grant awards (5)
Ribosomal Frameshifting in HIV-1 Infection, Inflammation and Neurotoxicity$601,307
R01 · FY2025 · NS · contact PI
Transcriptional regulation of ACE2 and the adaption of SARS-CoV-2$192,500
R21 · FY2024 · AI · contact PI
SMC1A/3 cohesin complex-mediated silencing of unintegrated HIV-1 DNA and the antagonism by Vpr$192,500
R21 · FY2024 · AI · contact PI
Transcriptional regulation of ACE2 and the adaption of SARS-CoV-2$231,000
R21 · FY2023 · AI · contact PI
SMC1A/3 cohesin complex-mediated silencing of unintegrated HIV-1 DNA and the antagonism by Vpr$231,000
R21 · FY2023 · AI · contact PI